Literature DB >> 10946973

Superparamagnetic iron oxide-enhanced MRI of atherosclerotic plaques in Watanabe hereditable hyperlipidemic rabbits.

S A Schmitz1, S E Coupland, R Gust, S Winterhalter, S Wagner, M Kresse, W Semmler, K J Wolf.   

Abstract

RATIONALE AND
OBJECTIVES: Inflammatory atherosclerotic plaques are characterized by increased endothelial permeability and multiple macrophages. Blood-pool MRI contrast agents like superparamagnetic iron oxide (SPIO) have an affinity for the monocyte-macrophage system and thus, may label inflammatory plaques. The objective was to demonstrate SPIO uptake in plaques of atherosclerotic rabbits by MRI and histology.
METHODS: Aortas of anesthetized Watanabe hereditable hyperlipidemic rabbits were studied with a moderately T2*-weighted gradient-echo sequence at 1.5 T. Four groups of five animals each were studied: (1) without ultrasmall SPIO (carboxydextran coating; particle size, 25 nm; estimated plasma half-life, 6 hours) or with imaging after intravenous injection of SPIO at a dose (micromol Fe/kg) and postcontrast time delay (hours) of 50/8 (2), 50/24 (3), or 200/48 (4). In vivo MRI was compared with corresponding ex vivo histological iron stains.
RESULTS: Animals receiving 200 micromol Fe/kg demonstrated areas of focal signal loss clearly confined to the aortic wall on a mean of 24 +/- 9 (31% +/- 11%) of 76 +/- 5 images compared with 0 +/- 0 of 76 +/- 5 images in controls (P = 0.009). The number of images with this finding in groups 2 and 3 was not significantly different compared with controls. By microscopy, SPIO-iron was seen in the endothelial cells and subendothelial intimal macrophages of atherosclerosis-prone aortic wall segments. Atherosclerotic lesions demonstrating iron uptake also showed a high macrophage content.
CONCLUSIONS: SPIO accumulates in aortic plaques of atherosclerotic rabbits, producing a characteristic MRI finding. As SPIO accumulates in plaques with increased endothelial permeability and a high macrophage content, two established features of plaque inflammation, it may have a potential for noninvasive assessment of inflammatory atherosclerotic plaques.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10946973     DOI: 10.1097/00004424-200008000-00002

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  48 in total

Review 1.  New developments in the detection of vulnerable plaque.

Authors:  M Naghavi; M Madjid; M R Khan; R M Mohammadi; J T Willerson; S W Casscells
Journal:  Curr Atheroscler Rep       Date:  2001-03       Impact factor: 5.113

Review 2.  Magnetic resonance imaging of coronary atherosclerosis.

Authors:  Zahi A Fayad; Robin P Choudhury; Valentin Fuster
Journal:  Curr Atheroscler Rep       Date:  2003-09       Impact factor: 5.113

Review 3.  Targeting the vulnerable plaque: the evolving role of nuclear imaging.

Authors:  John R Davies; James F Rudd; Tim D Fryer; Peter L Weissberg
Journal:  J Nucl Cardiol       Date:  2005 Mar-Apr       Impact factor: 5.952

4.  Identification of interleukin-2 for imaging atherosclerotic inflammation.

Authors:  Zahi A Fayad; Vardan Amirbekian; Jean-François Toussaint; Valentin Fuster
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-02       Impact factor: 9.236

Review 5.  [Advances in cardiovascular medicine through molecular imaging].

Authors:  M Nahrendorf; R Weissleder
Journal:  Radiologe       Date:  2007-01       Impact factor: 0.635

Review 6.  Advances in detection and characterization of atherosclerosis using contrast agents targeting the macrophage.

Authors:  Michael J Lipinski; Juan Carlos Frias; Zahi A Fayad
Journal:  J Nucl Cardiol       Date:  2006-09       Impact factor: 5.952

Review 7.  MR-optical imaging of cardiovascular molecular targets.

Authors:  Matthias Nahrendorf; David E Sosnovik; Ralph Weissleder
Journal:  Basic Res Cardiol       Date:  2008-03       Impact factor: 17.165

8.  Ex-vivo cellular MRI with b-SSFP: quantitative benefits of 3T over 1.5 T.

Authors:  Soha Said Ramadan; Chris Heyn; Lisa T Mackenzie; Ann F Chambers; Brian K Rutt; Paula J Foster
Journal:  MAGMA       Date:  2008-06-25       Impact factor: 2.310

9.  Gadolinium-Based Contrast Agents for Vessel Wall Magnetic Resonance Imaging (MRI) of Atherosclerosis.

Authors:  Claudia Calcagno; Sarayu Ramachandran; Antoine Millon; Philip M Robson; Venkatesh Mani; Zahi Fayad
Journal:  Curr Cardiovasc Imaging Rep       Date:  2012-10-14

10.  Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis.

Authors:  Matthias Nahrendorf; Hanwen Zhang; Sheena Hembrador; Peter Panizzi; David E Sosnovik; Elena Aikawa; Peter Libby; Filip K Swirski; Ralph Weissleder
Journal:  Circulation       Date:  2007-12-24       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.